Safety of Revascularization Deferral of Left Main Stenosis Based on Instantaneous Wave-Free Ratio Evaluation

Takayuki Warisawa1, Christopher M Cook2, Christopher Rajkumar2

  • 1National Heart and Lung Institute, Imperial College London, London, United Kingdom; Department of Cardiovascular Medicine, St. Marianna University School of Medicine Yokohama City Seibu Hospital, Yokohama, Japan.

Insights

Deferring left main coronary artery stenosis treatment based on the instantaneous wave-free ratio (iFR) showed similar long-term safety and clinical outcomes compared to revascularization. This suggests iFR is a safe tool for guiding treatment decisions in these patients.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Clinical Outcomes Research

Background:

  • The instantaneous wave-free ratio (iFR) is established for guiding revascularization in stable coronary artery disease.
  • Safety data for deferring left main (LM) coronary artery stenosis treatment based on iFR is lacking.
  • LM stenosis requires careful consideration due to its critical location and potential for severe outcomes.

Purpose of the Study:

  • To evaluate the long-term clinical outcomes of patients with left main (LM) coronary artery stenosis.
  • To assess the safety of deferring revascularization based on the instantaneous wave-free ratio (iFR) in LM stenosis.
  • To compare outcomes between deferred and revascularized LM stenosis guided by iFR.

Main Methods:

  • Multicenter observational study of 314 patients with LM stenosis.
  • Patients were divided into deferred (n=163) or revascularized (n=151) groups based on iFR cutoff ≤0.89.
  • Primary endpoint: composite of all-cause death, nonfatal myocardial infarction, and ischemia-driven target lesion revascularization over a median 30-month follow-up.

Main Results:

  • No significant difference in the primary endpoint between deferred (9.2%) and revascularized (14.6%) groups (p=0.26).
  • Similar rates for secondary endpoints including all-cause death, cardiac death, nonfatal myocardial infarction, and target lesion revascularization between groups (p>0.05 for all).
  • Hazard ratio for the primary endpoint was 1.45 (95% CI: 0.75 to 2.81) favoring the deferred group.

Conclusions:

  • Deferral of revascularization for LM stenosis guided by iFR appears safe.
  • Long-term clinical outcomes are comparable to those undergoing revascularization based on iFR values.
  • iFR is a reliable physiological index for guiding management decisions in LM coronary artery stenosis.
Abstract

Related Concept Videos